Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
TRENARY C RUSSELL III
CEO and President at Outlook Therapeutics. Filing since 2 Dec 2021.
CIK 0001227307
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
21 Jun 2022
CEO and President
Bought
19,925
$21.12K
56.9%
OTLK
Outlook Therapeutics, Inc.
6 Dec 2021
CEO and President
Bought
25,000
$34.75K
250%
OTLK
Outlook Therapeutics, Inc.
2 Dec 2021
CEO and President
Bought
10,000
$14.00K
opened
3 decisions on file.
